Peter A Singer

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi Interdisciplinary research: putting the methods under the microscope
    David W Robertson
    Department of Psychiatry, University of Toronto, Toronto, Ontario, M5S 1A1, Canada
    BMC Med Res Methodol 3:20. 2003
  2. ncbi Consensus guidelines on analgesia and sedation in dying intensive care unit patients
    Laura A Hawryluck
    Ian Anderson Continuing Education Program In End of Life Care, Toronto Canada
    BMC Med Ethics 3:E3. 2002
  3. ncbi Waiting lists for radiation therapy: a case study
    D P D'Souza
    Department of Radiation Oncology, Hamilton Regional Cancer Centre, McMaster University, Canada
    BMC Health Serv Res 1:3. 2001
  4. ncbi Deeper lessons from the CMAJ debacle
    Peter A Singer
    University of Toronto Joint Centre for Bioethics, Toronto, Ontario M5G 1L4, Canada
    Lancet 367:1551-3. 2006
  5. ncbi Clinical ethics revisited
    Peter A Singer
    Sun Life Chair and Director, University of Toronto Joint Centre for Bioethics Professor of Medicine, University of Toronto
    BMC Med Ethics 2:E1. 2001
  6. ncbi Harnessing genomics and biotechnology to improve global health equity
    P A Singer
    Joint Centre for Bioethics and Departments of Medicine, Public Health Sciences, and Surgery, University of Toronto, Toronto, Canada
    Science 294:87-9. 2001
  7. ncbi Grand challenges in global health: the ethical, social and cultural program
    Peter A Singer
    McLaughlin-Rotman Centre for Global Health and the Department of Medicine at the University of Toronto, Toronto, Ontario, Canada
    PLoS Med 4:e265. 2007
  8. ncbi Motivating action: why should Canadian physicians participate in research, education, or patient care in the developing world?
    Peter A Singer
    McLaughlin Rotman Centre for Global Health, University Health Network, and University of Toronto in Ontario
    Can Fam Physician 53:1849-51, 1863-5. 2007
  9. ncbi Strengthening the role of ethics in medical education
    Peter A Singer
    University of Toronto Joint Centre for Bioethics, University of Toronto, Toronto, ON
    CMAJ 168:854-5. 2003
  10. ncbi Applying genomics-related technologies for Africa's health needs
    P A Singer
    University of Toronto Joint Centre for Bioethics, Toronto, Canada
    Afr J Med Med Sci 36:7-14. 2007

Detail Information

Publications110 found, 100 shown here

  1. ncbi Interdisciplinary research: putting the methods under the microscope
    David W Robertson
    Department of Psychiatry, University of Toronto, Toronto, Ontario, M5S 1A1, Canada
    BMC Med Res Methodol 3:20. 2003
    ..While the desirability of interdisciplinary inquiry has been widely acknowledged, indeed has become 'the mantra of science policy', the methods of interdisciplinary collaboration are opaque to outsiders and generally remain undescribed...
  2. ncbi Consensus guidelines on analgesia and sedation in dying intensive care unit patients
    Laura A Hawryluck
    Ian Anderson Continuing Education Program In End of Life Care, Toronto Canada
    BMC Med Ethics 3:E3. 2002
    ..The goal of this study is to develop consensus guidelines on analgesia and sedation in dying intensive care unit patients that help distinguish palliative care from euthanasia...
  3. ncbi Waiting lists for radiation therapy: a case study
    D P D'Souza
    Department of Radiation Oncology, Hamilton Regional Cancer Centre, McMaster University, Canada
    BMC Health Serv Res 1:3. 2001
    ....
  4. ncbi Deeper lessons from the CMAJ debacle
    Peter A Singer
    University of Toronto Joint Centre for Bioethics, Toronto, Ontario M5G 1L4, Canada
    Lancet 367:1551-3. 2006
  5. ncbi Clinical ethics revisited
    Peter A Singer
    Sun Life Chair and Director, University of Toronto Joint Centre for Bioethics Professor of Medicine, University of Toronto
    BMC Med Ethics 2:E1. 2001
    ....
  6. ncbi Harnessing genomics and biotechnology to improve global health equity
    P A Singer
    Joint Centre for Bioethics and Departments of Medicine, Public Health Sciences, and Surgery, University of Toronto, Toronto, Canada
    Science 294:87-9. 2001
    ..But how can genomics be systematically harnessed to benefit health in developing countries? We propose a five-point strategy, including research, capacity strengthening, consensus building, public engagement, and an investment fund...
  7. ncbi Grand challenges in global health: the ethical, social and cultural program
    Peter A Singer
    McLaughlin-Rotman Centre for Global Health and the Department of Medicine at the University of Toronto, Toronto, Ontario, Canada
    PLoS Med 4:e265. 2007
  8. ncbi Motivating action: why should Canadian physicians participate in research, education, or patient care in the developing world?
    Peter A Singer
    McLaughlin Rotman Centre for Global Health, University Health Network, and University of Toronto in Ontario
    Can Fam Physician 53:1849-51, 1863-5. 2007
  9. ncbi Strengthening the role of ethics in medical education
    Peter A Singer
    University of Toronto Joint Centre for Bioethics, University of Toronto, Toronto, ON
    CMAJ 168:854-5. 2003
  10. ncbi Applying genomics-related technologies for Africa's health needs
    P A Singer
    University of Toronto Joint Centre for Bioethics, Toronto, Canada
    Afr J Med Med Sci 36:7-14. 2007
    ..are most likely to improve the health of people in developing countries?; How can developing countries harness these technologies for health development?; and What can industrialized countries do to assist developing countries?..
  11. ncbi Ethics and SARS: lessons from Toronto
    Peter A Singer
    University of Toronto Joint Centre for Bioethics, 88 College St, Toronto, Canada M5G 1L4
    BMJ 327:1342-4. 2003
  12. ncbi Consent to the publication of patient information
    Peter A Singer
    University of Toronto Joint Centre for Bioethics, 88 College St, Toronto, Canada M5G 1L4
    BMJ 329:566-8. 2004
  13. ncbi Priority setting for new technologies in medicine: qualitative case study
    P A Singer
    University of Toronto Joint Centre for Bioethics, Toronto, ON, Canada M5G 1L4
    BMJ 321:1316-8. 2000
    ..To describe priority setting for new technologies in medicine...
  14. ncbi Bioethics for clinicians: 6. Advance care planning
    P A Singer
    University of Toronto Joint Centre for Bioethics, Toronto ON
    CMAJ 155:1689-92. 1996
    ....
  15. ncbi Quality end-of-life care: patients' perspectives
    P A Singer
    Toronto Hospital and the Department of Medicine, Joint Centre for Bioethics, University of Toronto, Ontario, Canada
    JAMA 281:163-8. 1999
    ..Quality end-of-life care is increasingly recognized as an ethical obligation of health care providers, both clinicians and organizations. However, this concept has not been examined from the perspective of patients...
  16. ncbi Performance-based assessment of clinical ethics using an objective structured clinical examination
    P A Singer
    Department of Medicine, University of Toronto Faculty of Medicine, Ontario, Canada
    Acad Med 71:495-8. 1996
    ..To further examine the objective structured clinical examination (OSCE) as a performance-based assessment method for clinical ethics...
  17. ncbi Bioethics for clinicians: 15. Quality end-of-life care
    P A Singer
    University of Toronto Joint Centre for Bioethics, ON
    CMAJ 159:159-62. 1998
    ..This 3-part framework can be used by clinicians at the bedside to focus their effort in improving the quality of end-of-life care...
  18. ncbi Leadership and priority setting: the perspective of hospital CEOs
    David Reeleder
    Department of Health Policy, Management and Evaluation, Faculty of Medicine, University of Toronto, Health Sciences Building, 155 College Street, Suite 425, Toronto, Ont, Canada M5T 3M6
    Health Policy 79:24-34. 2006
    ..It also provides a leadership guide for decision makers to improve the quality of their leadership, and in so doing, we believe, the fairness of their priority setting...
  19. ncbi Introduction: promoting global health through biotechnology
    Halla Thorsteinsdóttir
    Canadian Program on Genomics and Global Health, University of Toronto Joint Centre for Bioethics and Department of Public Health Sciences, 88 College Street, Toronto, Ontario M5G 1L4, Canada
    Nat Biotechnol 22:DC3-7. 2004
  20. ncbi How can developing countries harness biotechnology to improve health?
    Abdallah S Daar
    The Program on Life Sciences, Ethics and Policy of the McLaughlin Rotman Centre for Global Health, University Health Network McLaughlin Centre for Molecular Medicine, University of Toronto, Ontario, Canada
    BMC Public Health 7:346. 2007
    ..The overall objective of the courses was to collectively explore how to best harness genomics to improve health in each region. This article presents and analyzes the recommendations from all five courses...
  21. ncbi What do hospital decision-makers in Ontario, Canada, have to say about the fairness of priority setting in their institutions?
    David Reeleder
    Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
    BMC Health Serv Res 5:8. 2005
    ..The purpose of this study is to elicit hospital decision-makers' self-report of the fairness of priority setting in their hospitals using an explicit conceptual framework, 'accountability for reasonableness'...
  22. ncbi South Korean biotechnology--a rising industrial and scientific powerhouse
    Joseph Wong
    Dept. of Political Science, University of Toronto, 100 St. George St, Toronto, Ontario, M5S 3G3, Canada
    Nat Biotechnol 22:DC42-7. 2004
  23. ncbi Healthcare sustainability and the challenges of innovation to biopharmaceuticals in Canada
    Zahava R S Rosenberg-Yunger
    Department of Health Policy Management and Evaluation and the Joint Centre for Bioethics, University of Toronto, Canada
    Health Policy 87:359-68. 2008
    ....
  24. ncbi Globetrotting firms: Canada's health biotechnology collaborations with developing countries
    Monali Ray
    McLaughlin Rotman Centre for Global Health, University Health Network and University of Toronto, Toronto, Ontario, Canada
    Nat Biotechnol 27:806-14. 2009
    ..A survey of Canadian biotech firms reveals that their biotech collaborations with developing countries are not only significant but also increasingly reciprocal in terms of the exchange of financial resources and technological know-how...
  25. ncbi Universal health care, genomic medicine and Thailand: investing in today and tomorrow
    Beatrice Seguin
    McLaughlin Rotman Centre for Global Health, Program on Life Sciences, Ethics and Policy, University Health Network and University of Toronto, MaRS Centre, South Tower, Suite 406, 101 College Street, Toronto, Ontario M5G 1L7, Canada
    Nat Rev Genet 9:S14-9. 2008
    ..A major future challenge will be for Thailand to integrate genomic medicine in its relatively young universal health-care system...
  26. ncbi Hospital priority setting with an appeals process: a qualitative case study and evaluation
    Shannon Madden
    Department of Health Policy, Management and Evaluation and the Joint Centre for Bioethics, University of Toronto, 88 College Street, Toronto, Ont, Canada M5G 1L4
    Health Policy 73:10-20. 2005
    ..Also, we compared the lessons learned from this study with those from a previous study at a different hospital...
  27. ncbi Public engagement on global health challenges
    Emma R M Cohen
    McLaughlin Rotman Centre for Global Health, University Health Network and University of Toronto, Canada
    BMC Public Health 8:168. 2008
    ..However, public engagement in the developing world regarding S&T risks and benefits to explore health issues has not been widely explored...
  28. ncbi Cuba--innovation through synergy
    Halla Thorsteinsdóttir
    Canadian Program on Genomics and Global Health, University of Toronto Joint Centre for Bioethics and Department of Public Health Sciences, 88 College Street, Toronto, Ontario M5G 1L4, Canada
    Nat Biotechnol 22:DC19-24. 2004
  29. ncbi Evaluating priority setting success in healthcare: a pilot study
    Shannon L Sibbald
    School of Health Studies The University of Western Ontario London, Ontario, N6A 5B9, Canada
    BMC Health Serv Res 10:131. 2010
    ..The evaluation process was designed to examine the procedural and substantive dimensions of priority setting using a multi-methods approach, including a staff survey, decision-maker interviews, and document analysis...
  30. ncbi Evidence, economics and ethics: resource allocation in health services organizations
    Jennifer L Gibson
    University of Toronto Joint Centre for Bioethics, Ontario, Canada
    Healthc Q 8:50-9, 4. 2005
    ..Various approaches have been developed to assist decision-makers to set priorities in their organizations. The dominant approaches come from evidence-based medicine, economics and ethics...
  31. ncbi Regenerative medicine in Brazil: small but innovative
    Dominique S McMahon
    McLaughlin Rotman Centre for Global Health, University Health Network and University of Toronto, Toronto, ON, M5G 1L7, Canada
    Regen Med 5:863-76. 2010
    ..Here we present a comprehensive case study of RM in Brazil, including analysis of the current activity, the main motivations for engaging in RM and the remaining challenges to development in this field...
  32. ncbi Priority setting in hospitals: fairness, inclusiveness, and the problem of institutional power differences
    Jennifer L Gibson
    University of Toronto Joint Centre for Bioethics, 88 College Street, Toronto, Ont, Canada M5G 1L4
    Soc Sci Med 61:2355-62. 2005
    ....
  33. ncbi Brazilian health biotech--fostering crosstalk between public and private sectors
    Rahim Rezaie
    McLaughlin-Rotman Centre for Global Health, University Health Network and University of Toronto, MaRS Centre, South Tower, Suite 406, 101 College Street, Toronto, Ontario, M5G 1L7, Canada
    Nat Biotechnol 26:627-44. 2008
  34. ncbi Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN)
    Beatrice Seguin
    Béatrice Séguin is also at the Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario M5S 3M2, Canada
    Nat Rev Genet 9:S5-9. 2008
    ....
  35. ncbi Top 10 health care ethics challenges facing the public: views of Toronto bioethicists
    Jonathan M Breslin
    University of Toronto Joint Centre for Bioethics, 88 College Street, Toronto, Ontario, M5G 1L4, Canada
    BMC Med Ethics 6:E5. 2005
    ....
  36. ncbi Setting priorities in health care organizations: criteria, processes, and parameters of success
    Jennifer L Gibson
    University of Toronto Joint Centre for Bioethics, 88 College Street, Toronto, Ontario, M5G 1L4, Canada
    BMC Health Serv Res 4:25. 2004
    ..Very little has been reported from the perspective of Board members and senior managers about what criteria, processes and parameters of success they would use to set priorities fairly...
  37. ncbi Priority setting for new technologies in medicine: a transdisciplinary study
    Jennifer L Gibson
    University of Toronto Joint Centre for Bioethics, 88 College St, Toronto, Canada M5G 1L4
    BMC Health Serv Res 2:14. 2002
    ..Traditional approaches to priority setting for new technologies in medicine are insufficient and there is no widely accepted model that can guide decision makers...
  38. ncbi Strengthening the role of genomics in global health
    Tara Acharya
    University of Toronto, Toronto, Canada
    PLoS Med 1:e40. 2004
  39. ncbi Chinese health biotech and the billion-patient market
    Sarah E Frew
    McLaughlin-Rotman Centre for Global Health, University Health Network and University of Toronto, MaRS Centre, South Tower, Suite 406, 101 College Street, Toronto, Ontario, M5G 1L7, Canada
    Nat Biotechnol 26:37-53. 2008
  40. ncbi A tough transition
    Peter A Singer
    Program on Life Sciences, Ethics and Policy, at the McLaughlin-Rotman Centre for Global Health, Toronto, Canada
    Nature 449:160-3. 2007
  41. ncbi From diversity to delivery: the case of the Indian Genome Variation initiative
    Billie Jo Hardy
    McLaughlin Rotman Centre for Global Health, Program on Life Sciences, Ethics and Policy, University Health Network and University of Toronto, MaRS Centre, South Tower, Suite 406, 101 College Street, Toronto, Ontario M5G 1L7, Canada
    Nat Rev Genet 9:S9-14. 2008
    ..The IGV has recently developed the first large-scale database of genomic diversity in the Indian population that will facilitate research on disease predisposition, adverse drug reactions and population migration...
  42. ncbi Grand challenges in global health: ethical, social, and cultural issues based on key informant perspectives
    Kathryn Berndtson
    Program on Life Sciences, Ethics, and Policy, McLaughlin-Rotman Centre for Global Health, Toronto, Ontario, Canada
    PLoS Med 4:e268. 2007
  43. ncbi Small but tenacious: South Africa's health biotech sector
    Sara Al-Bader
    McLaughlin Rotman Centre for Global Health, University Health Network and University of Toronto, Toronto, Ontario, Canada
    Nat Biotechnol 27:427-45. 2009
    ..Despite a challenging business environment, entrepreneurial health biotech companies in South Africa are finding ways to succeed...
  44. ncbi The next steps for genomic medicine: challenges and opportunities for the developing world
    Billie Jo Hardy
    McLaughlin Rotman Centre for Global Health, Program on Life Sciences, Ethics and Policy, University Health Network and University of Toronto, MaRS Centre, South Tower, Suite 406, 101 College Street, Toronto, Ontario M5G 1L7, Canada
    Nat Rev Genet 9:S23-7. 2008
    ..Here we provide a perspective on the challenges and opportunities facing these and other countries in the developing world as they begin to harness genomics for the benefit of their populations...
  45. ncbi Participation in health care priority-setting through the eyes of the participants
    Douglas K Martin
    Department of Health Policy, Management and Evaluation, University of Toronto, 88 College Street, Toronto, Ontario M5G 1L4, Canada
    J Health Serv Res Policy 7:222-9. 2002
    ..CONCLUSIONS: Using the insights from decision-makers, we have described lessons related to direct involvement of members of the public and patients in priority-setting, and have identified six roles and the contributions of each role...
  46. ncbi South Africa: from species cradle to genomic applications
    Billie Jo Hardy
    McLaughlin Rotman Centre for Global Health, Program on Life Sciences, Ethics and Policy, University Health Network and University of Toronto, MaRS Centre, Toronto, Ontario M5G 1L7, Canada
    Nat Rev Genet 9:S19-23. 2008
    ..Public engagement in genomic issues is spear-headed by The Africa Genome Education Institute...
  47. ncbi Harnessing stem cells for health needs in India
    Bryn Lander
    McLaughlin Rotman Centre for Global Health, University Health Network and University of Toronto, Toronto, ON M5G 1L7, Canada
    Cell Stem Cell 3:11-5. 2008
    ..India demonstrates that stem cell research and development (R&D) is not confined to industrialized countries and has begun to harness stem cells to address its own health needs...
  48. ncbi Just regionalisation: rehabilitating care for people with disabilities and chronic illnesses
    Barbara Secker
    Joint Centre for Bioethics, University of Toronto, 88 College Street, Toronto, Ontario, Canada
    BMC Med Ethics 7:E9. 2006
    ..The critical success factors we provide have broad applicability for guiding and/or evaluating new and existing regionalised health care strategies...
  49. ncbi Grand challenges in chronic non-communicable diseases
    Abdallah S Daar
    Program on Life Sciences, Ethics and Policy, McLaughlin-Rotman Centre for Global Health, University Health Network/University of Toronto, 101 College Street, Toronto, Ontario, M5G 1L7, Canada
    Nature 450:494-6. 2007
  50. ncbi Grand challenges in global health: engaging civil society organizations in biomedical research in developing countries
    Anant Bhan
    Ethical, Social and Cultural Program for the Grand Challenges in Global Health Initiative, McLaughlin-Rotman Centre for Global Health, University of Toronto, Ontario, Canada
    PLoS Med 4:e272. 2007
  51. ncbi Lessons on ethical decision making from the bioscience industry
    Jocelyn E Mackie
    University of Toronto Joint Centre for Bioethics, Toronto, Ontario, Canada
    PLoS Med 3:e129. 2006
  52. ncbi Priority setting: what constitutes success? A conceptual framework for successful priority setting
    Shannon L Sibbald
    Department of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada
    BMC Health Serv Res 9:43. 2009
    ..One way to approach this problem is to determine what all relevant stakeholders understand successful priority setting to mean. The goal of this research was to develop a conceptual framework for successful priority setting...
  53. ncbi Genomic medicine and developing countries: creating a room of their own
    Beatrice Seguin
    McLaughlin Rotman Centre for Global Health, Program on Life Sciences, Ethics and Policy, University of Toronto, MaRS Centre, South Tower, Suite 406, 101 College Street, Toronto, Ontario M5G 1L7, Canada
    Nat Rev Genet 9:487-93. 2008
    ..A significant additional benefit is building the capacity for scientific research and internalizing advances in technology, whatever their source...
  54. ncbi The Indian and Chinese health biotechnology industries: potential champions of global health?
    Sarah E Frew
    McLaughlin Rotman Centre for Global Health, University Health Network and University of Toronto, in Ontario, Canada
    Health Aff (Millwood) 27:1029-41. 2008
    ..However, global health stakeholders, including international donors and the Indian and Chinese governments, will need to fashion incentives for these companies to retain a strategic focus on the global poor...
  55. ncbi A randomized trial of teaching bioethics to surgical residents
    Anja Robb
    Centre for Research in Education, University of Toronto, Toronto, Canada
    Am J Surg 189:453-7. 2005
    ..002). CONCLUSIONS: A traditional seminar was superior to an SP-based seminar for teaching informed consent to surgical residents...
  56. ncbi Cultivating regenerative medicine innovation in China
    Dominique S McMahon
    McLaughlin Rotman Centre for Global Health, University Health Network and University of Toronto, Toronto, Ontario, M5G 1L7, Canada
    Regen Med 5:35-44. 2010
    ..We analyze how capacity in regenerative medicine was built in China to identify some of its main strengths and challenges...
  57. ncbi Science community: scientific diasporas
    Beatrice Seguin
    Canadian Program on Genomics and Global Health, University of Toronto, and Joint Centre for Bioethics, 88 College Street, Toronto, Canada M5G 1L4
    Science 312:1602-3. 2006
  58. ncbi Biotechnology and the UN's Millennium Development Goals
    Tara Acharya
    University of Toronto Joint Center for Bioethics, University of Toronto, 88 College Street, Toronto, Ontario, M5G 1L4 Canada
    Nat Biotechnol 21:1434-6. 2003
  59. ncbi Nanotechnology and the developing world
    Fabio Salamanca-Buentello
    University of Toronto, Toronto, Canada
    PLoS Med 2:e97. 2005
  60. ncbi Evaluation of a multicenter ethics objective structured clinical examination
    P A Singer
    Department of Medicine, University of Toronto, Ontario, Canada
    J Gen Intern Med 9:690-2. 1994
    ..0004). The ethics OSCE has adequate interrater reliability and construct validity, but low internal consistency reliability. There are differences among the schools that may assist in ethics curriculum evaluation and development...
  61. ncbi Bioethics for clinicians: 4. Voluntariness
    E Etchells
    Department of Medicine, University of Toronto, Toronto Hospital, Ont
    CMAJ 155:1083-6. 1996
    ....
  62. ncbi Biotechnology to improve health in developing countries -- a review
    Tara Acharya
    Joint Centre for Bioethics, University of Toronto, 88 College St, Toronto ON, M5G-1L4, Canada
    Mem Inst Oswaldo Cruz 99:341-50. 2004
    ..Here we review these new and emerging biotechnologies and explore how they can be used to support the goals of developing countries in improving health...
  63. ncbi Fairness, accountability for reasonableness, and the views of priority setting decision-makers
    Douglas K Martin
    Department of Health Policy, Management and Evaluation, and the Joint Centre for Bioethics, University of Toronto, 88 College Street, Toronto, Ont M5G 1L4, Canada
    Health Policy 61:279-90. 2002
    ..According to these decision makers, accountability for reasonableness is acceptable and applicable. Our findings also provide refinements to accountability for reasonableness...
  64. ncbi Top ten biotechnologies for improving health in developing countries
    Abdallah S Daar
    Program in Applied Ethics and Biotechnology, Joint Centre for Bioethics, Department of Public Health Sciences, Pan American Health Organization/World Health Organization Collaborating Centre for Bioethics, University of Toronto, Ontario M5G 1 L4, Canada
    Nat Genet 32:229-32. 2002
    ..The results offer concrete guidance to those in a position to influence the direction of research and development, and challenge common assumptions about the relevance and affordability of biotechnology for developing countries...
  65. ncbi A visual dashboard for moving health technologies from "lab to village"
    Hassan Masum
    McLaughlin Rotman Centre for Global Health, University Health Network and University of Toronto, MaRS Centre, South Tower, Suite 406, 101 College Street, Toronto, ON M5G 1L7, Canada
    J Med Internet Res 9:e32. 2007
    ..The next step will be for groups interested in global health, and even the public via the Internet, to use the tool to help guide technologies down this tricky path to improve global health and foster human development...
  66. ncbi Genomics--a global public good?
    Halla Thorsteinsdóttir
    Canadian Program on Genomics and Global Health, Program in Applied Ethics and Biotechnology, University of Toronto, Ontario, M5G 1 L4, Toronto, Canada
    Lancet 361:891-2. 2003
  67. ncbi In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?
    James V Lavery
    Centre for Research on Inner City Health and Centre for Global Health Research, The Keenan Research Centre in the Li Ka Shing Knowledge Institute of St Michael s Hospital, Toronto, Ontario, Canada
    PLoS Med 6:e1000071. 2009
    ..But David Buchanan argues that the early stopping of trials for such opportunity costs would face insurmountable practical barriers, and would risk causing harm to the participants in the trial that was stopped...
  68. ncbi Venture funding for science-based African health innovation
    Hassan Masum
    McLaughlin Rotman Centre for Global Health, University Health Network and University of Toronto, 101 College Street Suite 406, Toronto ON, M5G 1L7, Canada
    BMC Int Health Hum Rights 10:S12. 2010
    ..If this is done, the proposed venture approach may have complementary benefits to existing initiatives and encourage local scientific and economic development while tapping new sources of funding...
  69. ncbi Pharmacogenetics and geographical ancestry: implications for drug development and global health
    Abdallah S Daar
    Canadian Program on Genomics and Global Health, University of Toronto Joint Centre for Bioethics, 88 College Street, Toronto, Ontario M5G 1L4, Canada
    Nat Rev Genet 6:241-6. 2005
    ....
  70. ncbi India's health biotech sector at a crossroads
    Sarah E Frew
    McLaughlin-Rotman Centre for Global Health, Program on Life Sciences, Ethics and Policy, University Health Network/McLaughlin Centre for Molecular Medicine at University of Toronto, Toronto, Ontario, Canada
    Nat Biotechnol 25:403-17. 2007
  71. ncbi Grand challenges in global health: community engagement in research in developing countries
    Paulina O Tindana
    Navrongo Health Research Centre in Navrongo, Ghana
    PLoS Med 4:e273. 2007
  72. ncbi Human-animal chimeras for vaccine development: an endangered species or opportunity for the developing world?
    Anant Bhan
    McLaughlin Rotman Centre for Global Health, University Health Network and University of Toronto, Toronto, Canada and Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
    BMC Int Health Hum Rights 10:8. 2010
    ..These would also serve as an important tool for the efficient testing of new vaccine candidates to streamline promising candidates for further trials in humans. However, developing human-animal chimeras has proved to be controversial...
  73. ncbi Harnessing biodiversity: the Malagasy Institute of Applied Research (IMRA)
    Manveen Puri
    McLaughlin Rotman Centre for Global Health, University Health Network and University of Toronto, 101 College Street Suite 406, Toronto ON, M5G 1L7, Canada
    BMC Int Health Hum Rights 10:S9. 2010
    ....
  74. ncbi 'Relief of oppression': an organizing principle for researchers' obligations to participants in observational studies in the developing world
    James V Lavery
    Centre for Research on Inner City Health and Centre for Global Health Research, Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael s Hospital, Toronto, Canada
    BMC Public Health 10:384. 2010
    ....
  75. ncbi Science-based health innovation in Ghana: health entrepreneurs point the way to a new development path
    Sara Al-Bader
    McLaughlin Rotman Centre for Global Health, at the University Health Network and University of Toronto, MaRS Centre, South Tower, Suite 406, 101 College Street, Toronto, Ontario, M5G 1L7, Canada
    BMC Int Health Hum Rights 10:S2. 2010
    ..Mobilizing stakeholders around health product development areas, such as traditional medicines and diagnostics, would help to create trust between groups and build a stronger health innovation system...
  76. ncbi Priority setting in surgery: improve the process and share the learning
    Douglas K Martin
    Department of Health Policy, Management, and Evaluation, University of Toronto, 88 College Street, Toronto, Ontario M5G 1L4, Canada
    World J Surg 27:962-6. 2003
    ....
  77. ncbi Bioethics for clinicians: 17. Conflict of interest in research, education and patient care
    T Lemmens
    Centre for Addiction and Mental Health, Toronto, Ont
    CMAJ 159:960-5. 1998
    ..Strategies include disclosing the conflict, establishing a system of review and authorization, and prohibiting the activities that lead to the conflict...
  78. ncbi Better governance in academic health sciences centres: moving beyond the Olivieri/Apotex Affair in Toronto
    L E Ferris
    Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    J Med Ethics 30:25-9. 2004
    ..Time alone will tell how sustainable and effective these changes are...
  79. ncbi Bioethics for clinicians: 13. Resource allocation
    M F McKneally
    Toronto Hospital, Ont
    CMAJ 157:163-7. 1997
    ..Clear, fair and publicly acceptable institutional and professional policies can help to ensure that resource allocation decisions are transparent and defensible...
  80. ncbi Bioethics for clinicians: 25. Teaching bioethics in the clinical setting
    M F McKneally
    University of Toronto
    CMAJ 164:1163-7. 2001
    ..We use 5 questions to focus the discussion: Why should I teach? What should I teach? How should I teach? How should I evaluate? How should I learn?..
  81. ncbi Bioethics for clinicians: 3. Capacity
    E Etchells
    University of Toronto Joint Centre for Bioethics, Department of Medicine, University of Toronto, Ont
    CMAJ 155:657-61. 1996
    ..If the assessment suggests that the patient is incapable, further assessment is generally recommended...
  82. ncbi Reconceptualizing advance care planning from the patient's perspective
    P A Singer
    University of Toronto Joint Centre for Bioethics, Department of Medicine, University of Toronto and Toronto Hospital, Ontario, Canada
    Arch Intern Med 158:879-84. 1998
    ..These assumptions about ACP have never been empirically validated...
  83. ncbi Stem cell research and transplantation: science leading ethics
    A S Daar
    University of Toronto Joint Centre for Bioethics, Toronto, Ontario, Canada
    Transplant Proc 36:2504-6. 2004
    ..Only in this way can we realize the great potential of stem cell research for organ transplantation...
  84. ncbi Bioethics for clinicians: 2. Disclosure
    E Etchells
    University of Toronto Joint Centre for Bioethics, Toronto, Ont
    CMAJ 155:387-91. 1996
    ..Clinicians may also need to be sensitive to cultural and religious beliefs that can affect disclosure...
  85. ncbi The ethics objective structured clinical examination
    P A Singer
    Department of Medicine, University of Toronto, Ontario, Canada
    J Gen Intern Med 8:23-8. 1993
    ..Ethics OSCE stations may be suitable for evaluating the ability of medical students and residents to address selected clinical-ethical situations...
  86. ncbi Clinical bioethics integration, sustainability, and accountability: the Hub and Spokes Strategy
    S MacRae
    University of Toronto Joint Centre for Bioethics, Toronto, Ontario, Canada
    J Med Ethics 31:256-61. 2005
    ..The goal of the Hub and Spokes Strategy is to foster an ethical climate and strengthen ethics capacity broadly throughout healthcare settings as well as create models in clinical bioethics that are excellent and effective...
  87. ncbi Access to intensive care unit beds for neurosurgery patients: a qualitative case study
    D K Martin
    Department of Health Policy, Management and Evaluation, University of Toronto, Canada
    J Neurol Neurosurg Psychiatry 74:1299-303. 2003
    ....
  88. ncbi Origins of the desire for euthanasia and assisted suicide in people with HIV-1 or AIDS: a qualitative study
    J V Lavery
    University of Toronto Joint Centre for Bioethics, Toronto, Ontario, Canada
    Lancet 358:362-7. 2001
    ..However, the question of why people desire euthanasia or assisted suicide has not been coherently answered. We aimed to answer this question in a specific group of patients...
  89. ncbi Priority-setting decisions for new cancer drugs: a qualitative case study
    D K Martin
    Department of Health Policy, Management and Evaluation and Public Health Sciences, M5G 1L4, Ontario, Canada
    Lancet 358:1676-81. 2001
    ..INTERPRETATION: Observing priority-setting decisions and their rationales in actual practice reveals lessons not contained in theoretical accounts...
  90. ncbi Chinese seniors' perspectives on end-of-life decisions
    K W Bowman
    Mount Sinai Hospital, Toronto, Ont, Canada
    Soc Sci Med 53:455-64. 2001
    ....
  91. ncbi Which advance directive do patients prefer?
    M Reinders
    Department of Family Medicine, University of Toronto, Ontario, Canada
    J Gen Intern Med 9:49-51. 1994
    ..Therefore, different people like different directives, and a variety of directives should be available for patients to review before they complete one...
  92. ncbi Ontario's formulary committee: how recommendations are made
    Anne M PausJenssen
    Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
    Pharmacoeconomics 21:285-94. 2003
    ....
  93. ncbi Clinical ethicists' perspectives on organisational ethics in healthcare organisations
    D S Silva
    University of Toronto Joint Centre for Bioethics, 88 College St, Toronto, Ontario M5G1L4, Canada
    J Med Ethics 34:320-3. 2008
    ..The role of clinical ethicists in, and perspective on, organisational ethics has not been well described or documented in the literature...
  94. ncbi Assessment of patient capacity to consent to treatment
    E Etchells
    Department of Medicine, The Toronto Hospital, University of Toronto, Toronto, Ont, Canada
    J Gen Intern Med 14:27-34. 1999
    ..Clinicians can use these practical, flexible, and evaluated measures as the initial step in the assessment of patient capacity to consent to treatment...
  95. ncbi Hospital policy on appropriate use of life-sustaining treatment. University of Toronto Joint Centre for Bioethics/Critical Care Medicine Program Task Force
    P A Singer
    University of Toronto Joint Centre for Bioethics, Ontario, Canada
    Crit Care Med 29:187-91. 2001
    ..CONCLUSIONS: This article describes the key issues faced by the Task Force while developing its policy. It will provide a useful starting point for other groups developing policy on appropriate use of life-sustaining treatment...
  96. ncbi The HIV-specific advance directive
    P A Singer
    University of Toronto Joint Centre for Bioethics, Department of Medicine, University of Toronto, Canada
    J Gen Intern Med 12:729-35. 1997
    ..They should be offered a disease-specific advance directive. Our findings should also encourage investigators to develop and evaluate disease-specific advance directives in other clinical settings...
  97. ncbi Conclusions: promoting biotechnology innovation in developing countries
    Halla Thorsteinsdóttir
    Canadian Program on Genomics and Global Health, University of Toronto Joint Centre for Bioethics and Dept of Public Health Sciences, 88 College Street, Toronto, Ontario M5G 1L4 Canada
    Nat Biotechnol 22:DC48-52. 2004
  98. ncbi Priority setting in a hospital critical care unit: qualitative case study
    Jens Mielke
    University of Zimbabwe Medical School, Zimbabwe
    Crit Care Med 31:2764-8. 2003
    ....
  99. ncbi The emergence of Egyptian biotechnology from generics
    Basma Abdelgafar
    Department of Management, American University in Cairo, 113 Kasr El Aini Street, P.O. Box 2511, 11511 Cairo, Egypt
    Nat Biotechnol 22:DC25-30. 2004
  100. ncbi South Africa--blazing a trail for African biotechnology
    Marion Motari
    UNU-INTECH-MERIT Programme, United Nations University, Institute for New Technologies, Keizer Karelplein 19, 6211 TC Maastricht, The Netherlands
    Nat Biotechnol 22:DC37-41. 2004
  101. ncbi Priority setting and cardiac surgery: a qualitative case study
    Nancy A Walton
    Faculty of Community Services, The School of Nursing, Ryerson University, 350 Victoria Street, Toronto, Ont, Canada M5B 2K3
    Health Policy 80:444-58. 2007
    ..The purpose of this study is to describe priority setting in cardiac surgery and evaluate it using an ethical framework, "accountability for reasonableness"...